DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MM New York, USA, May 01, 2023 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MM ...

Antibody Drug Conjugate Market, a $13.15 billion Industry by 2030 with a CAGR of 14.12 % New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The surge in the antibody-drug conjugates market growth is due to rising cancer cases globally, technological advancements in medical...